Showing results (1-10 of 299) with videos related to
Sort By:
Pageof 30
Seminars in Oncology|February 1, 1996
Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancerU Klaassen, A Harstrick, H Wilke, et al.Oncology (Williston Park, N.Y.)|March 28, 1998
Fluorouracil-based combinations in the treatment of metastatic breast cancerU Klaassen, H Wilke, A Harstrick, et al.Seminars in Oncology|March 4, 2000
Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinicU Vanhoefer, N Schleucher, U Klaassen, et al.Anti-Cancer Drugs|June 23, 1998
Paclitaxel plus ifosfamide in advanced ovarian cancer: results of a phase I studyU Klaassen, A Harstrick, D Strumberg, et al.Anti-Cancer Drugs|June 1, 1996
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell linesD Strumberg, A Harstrick, K Doll, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)U Vanhoefer, S Cao, A Harstrick, et al.Journal of Clinical Apheresis|August 10, 1999
Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral blood stem cellsP Bojko, N Nowak, T Moritz, et al.Seminars in Oncology|November 28, 1997
Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, C Müller, et al.Anti-Cancer Drugs|April 1, 1997
Drug interactions of 5-fluorouracil with either cisplatin or lobaplatin--a new, clinically active platinum analog in established human cancer cell linesA Harstrick, U Vanhoefer, A Heidemann, et al.Pageof 30